CMT Research Foundation Advisors

George Simpson

Public Relations Director

George launched his own corporate communications firm in 1986. Over more than three decades, he worked for hundreds of traditional and new media companies including content providers, all manner of online ad targeting firms from behavioral to semantic to contextual, ad exchanges, mobile ad networks, vertical ad networks, ad serving companies, data providers, advanced TV, attribution companies and others with a play in digital advertising. Before starting his own business, George worked with NEWSWEEK in marketing and corporate communications from 1972 to 1985 and was Vice President of Corporate Communications for SIMON & SCHUSTER in 1985 and 1986. He holds a BA in Journalism from the University of North Carolina.

Kim Hunter-Schaedle, Ph.D.

Scientific Consultant

Kim is a neurobiologist and non-profit research administrator. She trained as a laboratory neurobiologist, earning her Ph.D. at King’s College London, then worked as a research scientist at St. Georges Hospital in London, The Rockefeller University in New York City, and Ontogeny, Inc. Kim then moved into non-profit research administration.  At the Juvenile Diabetes Research Foundation, she headed the diabetes complications grant portfolio. As well as overseeing funding in neuropathy, retinopathy, nephropathy and vascular disease, she managed a glucose sensors research collaboration with the Department of the Army and a retinopathy telemedicine initiative with the National Eye Institute.

After a short stint in technology transfer with Columbia University Science & Technology Ventures, Kim served as the first Chief Scientific Officer of the Children’s Tumor Foundation, designing and launching a transformative research program portfolio to advance therapeutic development for the rare disease neurofibromatosis. She then joined the Austen Riggs Center, a private residential psychiatric hospital serving as Chief of Staff, then as IRB Administrator.

Kim has provided expert research operations guidance and services to the Melanoma Research Alliance, Breakthrough Type 1 Diabetes (formerly JDRF), the Avon Foundation, the William Guy Forbeck Research Foundation, the Neurofibromatosis Network and the Lupus Research Alliance.